Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2
Krzysztof Marycz,1,2 Agnieszka Śmieszek,1 Katarzyna Kornicka-Garbowska,1,2 Ariadna Pielok,1 Maciej Janeczek,3 Anna Lipińska,3 Anna Nikodem,4 Jarosław Filipiak,4 Paulina Sobierajska,5 Jean-Marie Nedelec,6 Rafał J Wiglusz2,5 1Department of Experimental Biolo...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-08-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/novel-nanohydroxyapatite-nhap-based-scaffold-doped-with-iron-oxide-nan-peer-reviewed-fulltext-article-IJN |
id |
doaj-39453bf5c66f4766be65baa8ffb21144 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marycz K Śmieszek A Kornicka-Garbowska K Pielok A Janeczek M Lipińska A Nikodem A Filipiak J Sobierajska P Nedelec JM Wiglusz RJ |
spellingShingle |
Marycz K Śmieszek A Kornicka-Garbowska K Pielok A Janeczek M Lipińska A Nikodem A Filipiak J Sobierajska P Nedelec JM Wiglusz RJ Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2 International Journal of Nanomedicine senile osteoporosis osteoblasts osteoclasts nanohydroxyapatite iron oxide nanoparticles small non-coding rna. |
author_facet |
Marycz K Śmieszek A Kornicka-Garbowska K Pielok A Janeczek M Lipińska A Nikodem A Filipiak J Sobierajska P Nedelec JM Wiglusz RJ |
author_sort |
Marycz K |
title |
Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2 |
title_short |
Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2 |
title_full |
Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2 |
title_fullStr |
Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2 |
title_full_unstemmed |
Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2 |
title_sort |
novel nanohydroxyapatite (nhap)-based scaffold doped with iron oxide nanoparticles (io), functionalized with small non-coding rna (mir-21/124) modulates expression of runt-related transcriptional factor 2 and osteopontin, promoting regeneration of osteoporotic bone in bilateral cranial defects in a senescence-accelerated mouse model (sam/p6). part 2 |
publisher |
Dove Medical Press |
series |
International Journal of Nanomedicine |
issn |
1178-2013 |
publishDate |
2021-08-01 |
description |
Krzysztof Marycz,1,2 Agnieszka Śmieszek,1 Katarzyna Kornicka-Garbowska,1,2 Ariadna Pielok,1 Maciej Janeczek,3 Anna Lipińska,3 Anna Nikodem,4 Jarosław Filipiak,4 Paulina Sobierajska,5 Jean-Marie Nedelec,6 Rafał J Wiglusz2,5 1Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Wroclaw, 50-375, Poland; 2International Institute of Translational Medicine, Malin, 55-124, Poland; 3Department of Biostructure and Animal Physiology, Wroclaw University of and Life Sciences, Wroclaw, 51-631, Poland; 4Department of Mechanics, Materials and Biomedical Engineering, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370 Wrocław, Poland; 5Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Okolna 2, 50-422 Wroclaw, Poland; 6Universite Clermont Auvergne, Clermont Auvergne INP, CNRS, ICCF, Clermont-Ferrand, FranceCorrespondence: Krzysztof MaryczThe Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences Wroclaw, Norwida 27B St, Wroclaw, 50– 375, PolandTel +48 71 320 5201Email krzysztof.marycz@upwr.edu.plPurpose: Healing of osteoporotic defects is challenging and requires innovative approaches to elicit molecular mechanisms promoting osteoblasts-osteoclasts coupling and bone homeostasis.Methods: Cytocompatibility and biocompatibility of previously characterised nanocomposites, i.e Ca5(PO4)3OH/Fe3O4 (later called nHAp/IO) functionalised with microRNAs (nHAp/IO@miR-21/124) was tested. In vitro studies were performed using a direct co-culture system of MC3T3-E1 pre-osteoblast and 4B12 pre-osteoclasts. The analysis included determination of nanocomposite influence on cultures morphology (confocal imaging), viability and metabolic activity (Alamar Blue assay). Pro-osteogenic signals were identified at mRNA, miRNA and protein level with RT-qPCR, Western blotting and immunocytochemistry. Biocompatibility of biomaterials was tested using bilateral cranial defect performed on a senescence-accelerated mouse model, ie SAM/P6 and Balb/c. The effect of biomaterial on the process of bone healing was monitored using microcomputed tomography.Results: The nanocomposites promoted survival and metabolism of bone cells, as well as enhanced functional differentiation of pre-osteoblasts MC3T3-E1 in co-cultures with pre-osteoclasts. Differentiation of MC3T3-E1 driven by nHAp/IO@miR-21/124 nanocomposite was manifested by improved extracellular matrix differentiation and up-regulation of pro-osteogenic transcripts, ie late osteogenesis markers. The nanocomposite triggered bone healing in a cranial defect model in SAM/P6 mice and was replaced by functional bone in Balb/c mice.Conclusion: This study demonstrates that the novel nanocomposite nHAp/IO can serve as a platform for therapeutic miRNA delivery. Obtained nanocomposite elicit pro-osteogenic signals, decreasing osteoclasts differentiation, simultaneously improving osteoblasts metabolism and their transition toward pre-osteocytes and bone mineralisation. The proposed scaffold can be an effective interface for in situ regeneration of osteoporotic bone, especially in elderly patients.Keywords: senile osteoporosis, osteoblasts, osteoclasts, nanohydroxyapatite, iron oxide nanoparticles, small non-coding RNA |
topic |
senile osteoporosis osteoblasts osteoclasts nanohydroxyapatite iron oxide nanoparticles small non-coding rna. |
url |
https://www.dovepress.com/novel-nanohydroxyapatite-nhap-based-scaffold-doped-with-iron-oxide-nan-peer-reviewed-fulltext-article-IJN |
work_keys_str_mv |
AT maryczk novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT smieszeka novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT kornickagarbowskak novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT pieloka novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT janeczekm novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT lipinskaa novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT nikodema novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT filipiakj novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT sobierajskap novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT nedelecjm novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene AT wigluszrj novelnanohydroxyapatitenhapbasedscaffolddopedwithironoxidenanoparticlesiofunctionalizedwithsmallnoncodingrnamir21124modulatesexpressionofruntrelatedtranscriptionalfactor2andosteopontinpromotingregenerationofosteoporoticboneinbilateralcranialdefectsinasene |
_version_ |
1717818873742360576 |
spelling |
doaj-39453bf5c66f4766be65baa8ffb211442021-09-02T22:02:45ZengDove Medical PressInternational Journal of Nanomedicine1178-20132021-08-01Volume 166049606568399Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2Marycz KŚmieszek AKornicka-Garbowska KPielok AJaneczek MLipińska ANikodem AFilipiak JSobierajska PNedelec JMWiglusz RJKrzysztof Marycz,1,2 Agnieszka Śmieszek,1 Katarzyna Kornicka-Garbowska,1,2 Ariadna Pielok,1 Maciej Janeczek,3 Anna Lipińska,3 Anna Nikodem,4 Jarosław Filipiak,4 Paulina Sobierajska,5 Jean-Marie Nedelec,6 Rafał J Wiglusz2,5 1Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Wroclaw, 50-375, Poland; 2International Institute of Translational Medicine, Malin, 55-124, Poland; 3Department of Biostructure and Animal Physiology, Wroclaw University of and Life Sciences, Wroclaw, 51-631, Poland; 4Department of Mechanics, Materials and Biomedical Engineering, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370 Wrocław, Poland; 5Institute of Low Temperature and Structure Research, Polish Academy of Sciences, Okolna 2, 50-422 Wroclaw, Poland; 6Universite Clermont Auvergne, Clermont Auvergne INP, CNRS, ICCF, Clermont-Ferrand, FranceCorrespondence: Krzysztof MaryczThe Department of Experimental Biology, The Faculty of Biology and Animal Science, University of Environmental and Life Sciences Wroclaw, Norwida 27B St, Wroclaw, 50– 375, PolandTel +48 71 320 5201Email krzysztof.marycz@upwr.edu.plPurpose: Healing of osteoporotic defects is challenging and requires innovative approaches to elicit molecular mechanisms promoting osteoblasts-osteoclasts coupling and bone homeostasis.Methods: Cytocompatibility and biocompatibility of previously characterised nanocomposites, i.e Ca5(PO4)3OH/Fe3O4 (later called nHAp/IO) functionalised with microRNAs (nHAp/IO@miR-21/124) was tested. In vitro studies were performed using a direct co-culture system of MC3T3-E1 pre-osteoblast and 4B12 pre-osteoclasts. The analysis included determination of nanocomposite influence on cultures morphology (confocal imaging), viability and metabolic activity (Alamar Blue assay). Pro-osteogenic signals were identified at mRNA, miRNA and protein level with RT-qPCR, Western blotting and immunocytochemistry. Biocompatibility of biomaterials was tested using bilateral cranial defect performed on a senescence-accelerated mouse model, ie SAM/P6 and Balb/c. The effect of biomaterial on the process of bone healing was monitored using microcomputed tomography.Results: The nanocomposites promoted survival and metabolism of bone cells, as well as enhanced functional differentiation of pre-osteoblasts MC3T3-E1 in co-cultures with pre-osteoclasts. Differentiation of MC3T3-E1 driven by nHAp/IO@miR-21/124 nanocomposite was manifested by improved extracellular matrix differentiation and up-regulation of pro-osteogenic transcripts, ie late osteogenesis markers. The nanocomposite triggered bone healing in a cranial defect model in SAM/P6 mice and was replaced by functional bone in Balb/c mice.Conclusion: This study demonstrates that the novel nanocomposite nHAp/IO can serve as a platform for therapeutic miRNA delivery. Obtained nanocomposite elicit pro-osteogenic signals, decreasing osteoclasts differentiation, simultaneously improving osteoblasts metabolism and their transition toward pre-osteocytes and bone mineralisation. The proposed scaffold can be an effective interface for in situ regeneration of osteoporotic bone, especially in elderly patients.Keywords: senile osteoporosis, osteoblasts, osteoclasts, nanohydroxyapatite, iron oxide nanoparticles, small non-coding RNAhttps://www.dovepress.com/novel-nanohydroxyapatite-nhap-based-scaffold-doped-with-iron-oxide-nan-peer-reviewed-fulltext-article-IJNsenile osteoporosisosteoblastsosteoclastsnanohydroxyapatiteiron oxide nanoparticlessmall non-coding rna. |